The healthcare that patients get before and after a stroke depends largely on the insurance they have — highlighting the differences between Medicare Advantage and traditional Medicare, a new study has found.
BUSINESS
Google Apologizes After News Alert Used The N-Word—Says It Wasn’t Related To AI
The alert was sharing news about an incident involving the racial slur at the BAFTA award ceremony.
‘Arco’ Is Now Streaming – How To Watch Best Animated Feature Oscar Nominee
The Best Animated Feature Oscar nominee “Arco,” starring the voices of Will Ferrell and Natalie Portman, is new on digital streaming. Find out where you can watch it at home.
Teens Use AI For Schoolwork—And Maybe To Cheat, New Survey Shows
Teachers have warned AI is hampering students’ ability to learn—but most of them are using it anyway.
AWS Debuts AI Vertical-Conversion Tools To Automate Live Sports Clips
AWS launches Elemental Inference tools to automate finding, clipping, adding meta data and distributing vertical video highlights from live sports events.
Social Security Isn’t Going Bankrupt, And Retirees Wouldn’t Care As Is
The U.S. is richer than ever, and retirees have a substantial majority of that wealth.
Trump’s Latest Tariff Flip-Flop: Opposing Refunds After Promising Them In Court
The Trump administration has suggested the refund issue could be tied up for years in court.
She Runs Google’s Massive Food Program — Here’s What Most Business Owners Completely Miss About Perks
Key Takeaways
Google’s attention to detail extends to their employee food program — a seemingly small perk with major implications.
Google uses AI to minimize waste, maximize value and make real-time decisions about what works when it comes to feeding its employees.
Google views its food program as an investment in creating informal spaces where collaboration happens naturally.
Food was never a perk at Google. It was a bet on how people work.
When Helen Wechsler, Senior Director, Food Program CoE at Google, talks about the company’s food program, she does not frame it as a benefit designed to impress.
Instead, she frames it as culture. From the earliest days, meals were how the original Google team gathered, talked and built trust. Long before sprawling campuses or polished cafes, food was the thing that brought them together and kept them there.
Today, Google provides meals and access to food for employees across its offices worldwide. Cafes, micro kitchens on every floor, coffee and tea bars, teaching kitchens and even food trucks are part of how the company feeds its people. The scale is massive, but Wechsler is clear that feeding employees is not about abundance.
“We have a captive audience,” she says. “We are feeding people every day, and that comes with a really weighty responsibility.”
Related: How to Land a Job at Google, According to a Former Manager
That responsibility is evident immediately in Google’s New York City offices, where I interviewed Wechsler. She offered me some of the spa water— I couldn’t believe how good it was.
For Wechsler, that reaction is exactly the point. “We just wanted people to drink more water,” she explains. “Spa water is a good way to do that.”
It sounds simple, almost insignificant. But those small choices are deliberate. Hydration stations that feel inviting. Details that spark curiosity. Moments that slow people down just enough to feel cared for. When food is free, indifference is the easiest failure. Wechsler calls it the shrug. Google refuses that approach.
Related: The Life-Changing Effects of Drinking More Water
“We want to be that joy in the day,” she says. “We want it to feel seamless.”
Hospitality, in this context, is not transactional. It is relational. Food becomes the cultural connector inside a highly technical environment. A reminder that no matter how advanced the work becomes, people still come together the same way they always have.
Over a meal.
Technology that cares
At Google’s scale, good intentions are not enough.
Feeding people well requires systems that can absorb uncertainty, adapt quickly and still leave room for care. Technology is what makes that possible — it protects hospitality at scale.
“Technology is your best friend if you use it correctly,” she says. “It helps you evaluate, helps you predict, helps you think in a different way.”
That philosophy shapes how Google approaches AI. The food team is not chasing automation for its own sake or looking for perfect answers. They are experimenting. Testing. Learning in public. AI becomes a tool to stretch thinking rather than narrow it.
“Play with it,” she says. “Use it, use it, use it.”
That mindset matters because Google operates with a level of unpredictability most restaurants never face. There is no register. No ordering funnel. No reliable way to know who will walk in on any given day. People come and go freely, which makes food waste a constant concern.
Related: Google Reportedly Told Its Staff to Use AI More or Risk Falling Behind
Over the past eight years, technology has helped bring clarity to that chaos. Menu management systems, recipe scaling and pre- and post-production records allow teams to compare what they expected to serve with what was actually eaten. The real breakthrough came when the data became visual.
“Until we started measuring it visually, it didn’t stick,” Wechsler says.
Today, waste is photographed, weighed and logged automatically. Images recognize the food, connect it to menus, and surface patterns that chefs can actually act on. If something consistently comes back untouched, it sparks a conversation. Maybe the recipe is wrong. Maybe the timing is off. Maybe it simply does not resonate.
Technology also supports creativity. Trim becomes spa water. Fruit scraps turn into new beverages. Excess ingredients find second lives in jams, chutneys or entirely new dishes. Measurement does not kill imagination. It fuels it.
The lesson for restaurants watching from the outside is simple. Technology should make people calmer, not busier. More thoughtful, not more reactive. When used well, it gives teams the space to care better.
Hospitality still belongs to humans. Technology just helps them see what matters.
About Restaurant Influencers
Restaurant Influencers is brought to you by Toast, the powerful restaurant point-of-sale and management system that helps restaurants improve operations, increase sales and create a better guest experience.
Toast — Powering Successful Restaurants. Learn more about Toast.
Read more: Want to Open a Restaurant? Here’s a Step-By-Step Guide
Here’s What Separates Companies Getting Real AI Results From Those Still Stuck in Pilot Mode
Key Takeaways
Most organizations are not struggling with AI innovation — they’re struggling with AI execution.
The real divide between winners and losers is the ability to turn pilots into production-ready systems with clear accountability, governance and measurable impact.
Production-ready AI must satisfy the following conditions: performance at scale, accuracy and context awareness, governance and auditability.
Artificial intelligence has dominated executive briefings, investor decks and earnings calls for the better part of three years. But here’s the part nobody likes to say out loud: Most organizations are not struggling with AI innovation — they’re struggling with AI execution.
Many initiatives look impressive in demos and pilots, but fail the moment they’re expected to operate inside a real business. They generate buzz. They produce slides. They never become production-ready systems that materially affect outcomes.
That gap between experimentation and production is where most AI initiatives die.
According to research from McKinsey & Company, while more than 70% of companies report adopting AI in at least one function, only a small minority say their efforts have translated into scaled, enterprise-level impact. The issue isn’t access to models or tooling. It’s the inability to take AI from proof-of-concept to production-ready deployment.
That disconnect between boardroom excitement and bottom-line reality tells us something important: The AI problem inside corporations isn’t technical. It’s executive and organizational.
This is not an abstract problem. It’s a leadership problem. It affects every executive who has approved an “AI initiative” because it sounded strategic, only to discover later that it wasn’t actionable, scalable or measurable.
The real reason AI projects die in pilot limbo
Across sectors from finance to healthcare to logistics, many AI initiatives stall before they ever deliver material business value. Gartner has repeatedly warned that a significant share of AI and generative AI projects fail to progress beyond pilot or proof-of-concept stages due to unclear business value, poor data readiness and governance gaps.
Why? The causes aren’t mysterious:
AI starts as a technology project, not a business solution: Teams build models without clearly defining the business problem or KPIs they are intended to affect.Leaders don’t define success clearly before execution: Expectations on accuracy, cost, risk tolerances and decision rights are often undefined or unrealistic.Accountability is fuzzy: When an AI system makes a bad recommendation inside a lending decision, pricing engine or clinical workflow, who owns the fallout? Rarely anyone with clear authority.
My experience: From buzz to business value
As a CEO, investor and founder, I’ve witnessed this pattern firsthand.
In 2024, my firm evaluated a mid-market financial services company that had invested millions in AI pilots. They had dashboards, proofs-of-concept and presentations, but no scalable deployments. Their models weren’t integrated with risk frameworks, approval workflows or governance guardrails. They failed not because the AI was bad, but because the organization never translated pilot insights into business execution.
This pattern repeats across industries: Organizations treat AI like a check in the innovation box, not a system with economic and operational constraints.
What “production-ready AI” actually means
There’s a phrase tossed around in tech circles: “production-ready AI.”
Leaders nod, but few can define it.
From an operator’s standpoint, production-ready AI must satisfy three conditions:
Performance at scale — consistent outputs across real customers and edge casesAccuracy and context awareness — decisions must consider real-world complexityGovernance and auditability — compliance, explainability and controls
When evaluating production readiness, the strongest teams stop treating AI as traditional software and instead model it as a decision-making agent inside the organization, one with autonomy, influence and real risk.
That shift changes how AI is designed and governed. Leaders explicitly define what the system is allowed to decide, what information it can access, when it must escalate to a human and who owns the outcome when it’s wrong. Without this structure, AI may perform well in isolation but fail once embedded in real workflows.
This is why ground truth validation, stress testing and ongoing performance review are not technical niceties — they are governance mechanisms. They determine whether an AI system can be trusted to operate at scale or whether it remains a controlled experiment. Without them, AI stays a demo. With them, it becomes operational.
Industry practitioners and applied AI researchers have consistently emphasized that rigorous production readiness testing, including stress testing and validation against real-world outcomes, is essential for successful deployment and long-term performance.
Why AI is a leadership problem — not a technical one
This is where executives get uncomfortable.
AI isn’t merely a software change. It changes behavior, incentives and decision pathways.
A recent Deloitte survey found that companies with strong AI governance frameworks were twice as likely to realize measurable returns on their AI investments.
That’s not accidental. When leaders insist on speed without clarity, governance and accountability fall by the wayside. Teams rush prototypes into workflows they don’t fully understand or control.
Effective AI governance means:
Clear decision rightsDefined escalation pathsHuman-in-the-loop checkpointsLoss limits and rollback procedures
Without these, AI becomes a forward-looking black box that executives don’t truly own.
The most common executive mistakes in AI
Based on my experience and supported by industry research, these are the executive behaviors that most frequently sink AI efforts:
Mistake #1 — Approving AI without clear success metrics: If you can’t define what a meaningful outcome looks like before you build it, you don’t have an AI project; you have a guess.Mistake #2 — Avoiding understanding because of “technical complexity”: If leadership can’t summarize the solution in business terms, it’s not ready to be operationalized.Mistake #3 — Treating AI as a shortcut to innovation instead of a strategic capability: Speed without structure leads to brittle systems that fail when exposed to real use cases.
Toward an era of executable AI
The gap between AI hype and real outcomes isn’t closing by accident. It’s narrowing where organizations:
Align AI with business KPIsDefine accountability and governance up frontTreat deployment as phased delivery, not a one-time launchDemand measurable outcomes, not demo artifacts
AI doesn’t fail because it’s too advanced. It fails because leaders treat it like a slide deck exercise.
It’s time to stop celebrating pilots and start rewarding production impact.That’s when AI stops being a buzzword and starts being a business multiplier.
Sign up for the Entrepreneur Daily newsletter to get the news and resources you need to know today to help you run your business better. Get it in your inbox.
AbbVie makes $380 million ‘made in the U.S.’ move
The Chicago-based biopharmaceutical company AbbVie made a significant move on Feb. 23, as part of its broader commitment to invest heavily in U.S. research and development over the next 10 years.AbbVie said it will invest$380 million to expand active pharmaceutical ingredient (API) manufacturing at its hometown campus in North Chicago, Illinois. The move is timely and deepens the White House’s push to drive supply chains back to the U.S., localize production, and control rising drug prices.The project will add two new, advanced manufacturing facilities in North Chicago, designed to support AbbVie’s next wave of medicines, particularly in neuroscience and metabolic disease. Construction is expected to begin in spring 2026, with operations coming online later in 2029. The pharmaceutical giant expects the expansion to create hundreds of high-skilled jobs, from engineers to specialists, starting from the first phase of establishment.AbbVie’s $100 billion promise to AmericaThis is the first of many investments expected from AbbVie and fits into its larger $100 billion promise to the Trump administration to reshape research in the U.S.On Jan. 12, AbbVie pledged $100 billion “in U.S.-based research and development and capital investments, including manufacturing, over the next decade.”
AbbVie’s stock is up 11% year over year.AbbVie
The aim is to make pharmaceutical drugs more affordable for Americans, expand access, and ensure U.S. innovation.As part of its investment prospects, the company will offer lower prices to Medicaid and increase its direct-to-patient offerings through TrumpRx for some of its widely used medications, including Alphagan, Combigan, Humira, and Synthroid.A changing Pharma landscapeThis past year has seen tremendous movement in the pharmaceutical industry. On the one hand, Eli Lilly became the first pharma company to enter the $1 trillion market-cap group.On the other hand, weight-loss and diabetes-control drugs like Ozempic and Wegovy became more affordable for Americans. These medications also became available at TrumpRx.gov, officially launched on Feb. 5.More Health Care:If your Medicare plan was canceled, do this nowHealth care costs are the wild card in year-end tax planning22 million Americans hit by ACA health insurance cliff after vote failsAs part of the ongoing progress comes AbbVie, one of the world’s largest biopharmaceutical companies with operations in more than 70 countries. It has a presence in all 50 U.S. states and employs about 29,000 people, with more than 6,000 at its U.S. manufacturing sites.This $380 million expansion in North Chicago is a significant addition to this political push, which centers on lower prescription costs, reshoring critical production to the U.S., and strengthening its supply chain.AbbVie will hire 300 people to support these two new facilities, including scientists, engineers, manufacturing operators, and lab technicians.The new facility will feature state-of-the-art facilities and integrate artificial intelligence to produce the next generation of obesity and neuroscience medicines.This latest expansion highlights how aggressively the pharma giant is reshaping its U.S. manufacturing footprint. In September 2025, AbbVie broke ground on the first phase of a $195 million investment, starting construction of an API plant in North Chicago.The new facilities represent the second phase in its series of investments to accelerate U.S. manufacturing capabilities. Additionally, on January 12, it announced an agreement to acquire a device manufacturing facility in Tempe, Arizona, with plans to invest more than $175 million and create 200 positions at the site.Related: White House shares key plan to lower drug costs